SEOUL (Reuters) – South Korean drugmaker Samsung Biologics Co Ltd plans to invest 2 trillion won ($1.53 billion) through September 2025 to build a new factory in South Korea, the company said in a regulatory filing on Friday.
($1 = 1,304.7300 won)
(Reporting by Heekyong Yang; Editing by Muralikumar Anantharaman)